Bromodomain Inhibitors: Products

"Bromodomain Inhibitors" has 49 results in Products.
Sort by:
Results Per Page:

(+)-JQ1

Potent and selective BET bromodomain inhibitor; cell permeable

MZ 1

(+)-JQ1 based Degrader (PROTAC®) that preferentially degrades BRD4

I-BET 151 dihydrochloride

BET bromodomain inhibitor; also promotes differentiation of hiPSCs into megakaryocytes

dBRD9

Potent and selective BRD9 Degrader (PROTAC®)

XMD 8-92

ERK5/BMK1 inhibitor; also BRD4 inhibitor

I-BRD9

Potent and selective BRD9 inhibitor

cis MZ 1

Negative Control for MZ 1 (Cat. No. 6154)

dBET1

(+)-JQ1 based Degrader (PROTAC®) targeting BET bromodomains, active in vivo

dBRD9-A

Potent BRD9 Degrader (PROTAC®)

dBET6

Potent and selective (+)-JQ1 based Degrader (PROTAC®) targeting BET bromodomains, active in vivo

PFI 1

BET bromodomain inhibitor

Ischemin sodium salt

CBP inhibitor; cell permeable

Bromosporine

Broad spectrum bromodomain inhibitor

SGC-CBP30

Potent CBP/p300 BRD inhibitor

PFI 3

Potent and selective SMARCA2/4 and polybromo 1 inhibitor

BAZ2-ICR

Selective BAZ2 inhibitor

CPI 203

BET bromodomain inhibitor; arrests cell cycle at G1 phase

NI 57

Potent and selective BRPF bromodomain inhibitor

BI 9564

Potent and selective BRD9 and BRD7 inhibitor; orally active

(-)-JQ1

Negative control for (+)-JQ1

LP 99

Selective BRD7 and BRD9 inhibitor

ent-LP 99

Negative Control for LP 99

NVS-CECR2-1

Potent and selective CECR2 inhibitor

BAY 299

Potent and selective BRD1 and TAF1 inhibitor

TP 472N

Negative control for TP 472

TP 472

Potent BRD9/7 inhibitor

Lin28 1632

RNA binding protein Lin28 inhibitor; promotes mESC differentiation; also bromodomain inhibitor

OTX 015

BET bromodomain inhibitor; orally bioavailable

GSK 6853

Potent and selective BRPF1 inhibitor

GSK 9311 hydrochloride

Negative control for GSK 6853

L Moses dihydrochloride

High affinity and selective PCAF bromodomain inhibitor

AT 1

(+)-JQ1 based PROTAC® with selectivity for BRD4

I-BET 762

Potent and high affinity BET bromodomain inhibitor; anti-inflammatory; orally bioavailable.

TP 238

CECR2 and BPTF/FALZ inhibitor

VZ 185

Potent and selective BRD7/9 Degrader (PROTAC®)

cis-VZ 185

Negative control for VZ 185 (Cat. No. 6936)

CeMMEC1

TAF1 inhibitor

ARV 771

Potent BET bromodomain PROTAC®; also degrades BRD-tagged chimeric antigen receptors (CAR) in T cells

SIM1

Potent and selective trivalent BET Bromodomain Degrader (PROTAC®)

cis-SIM1

Negative control for SIM1 (Cat. No. 7432)

iBET-BD2

Potent and selective pan-BD2 inhibitor; orally bioavailable

SGC SMARCA-BRDVIII

Potent and selective SMARCA2/4 and PB1(bromo 5)-selective SWI/SNF bromodomain inhibitor

NVS MLLT-1

Selective MLLT1/3 inhibitor

(+)-JQ1 bump, acid functionalized

Functionalized BET bromodomain ligand; precursor for Tag Degraders

FHT 1015

Potent and selective SMARCA4/2 inhibitor

FHT 2344

Potent SMARCA2/4 inhibitor

AZ 13824374

Potent and selective ATAD2 bromodomain inhibitor

HHP 9

BET bromodomain Degrader (PROTAC®); also potent Hedgehog pathway inhibitor

JQ dS-4

BRG1/SMARCA4 Degrader (PROTAC®)
page of 1
Back to Search Results
Apply
FiltersClear All